Is BPC-157 approved for human use
Do not assume that a solvent recommendation for one suppliers salt form applies to every lot
The benzyl alcohol used in bacteriostatic water for injection slows microbial growth but does not stop chemical peptide degradation
Yang B et al
Research Overview In experimental and preclinical research contexts, the BPC-157 / TB-500 peptide combination is examined in laboratory systems investigating peptide-mediated signaling behavior, molecular interaction dynamics, and biochemical response pathways
Conditions include alcoholic liver disease, viral hepatitis, cirrhosis, and primary or metastatic liver cancer Renal dysfunction : Impaired kidney function reduces B12 elimination, causing accumulation even with normal intake Haematological conditions : Myeloproliferative neoplasms, chronic myeloid leukaemia, polycythaemia vera, and hypereosinophilic syndrome increase transcobalamin production, elevating total serum B12 Laboratory interference : Macro-B12 (immunoglobulin-bound B12) and assay interference can cause spuriously elevated results without true excess In clinical practice, unexplained hypercobalaminaemia should prompt investigation for underlying disease, particularly in patients without obvious supplementation history